Page 56 - Annual Report_21-22
P. 56

Figure:  (a-d)  Representative  CLSM  images  of  live/dead  staining  of    S.  sanguinis  in  response  to  pAgNCs
                    treatment and relevant controls (e) quantitative analysis of bacteria viability (%). (f – i) CLSM images of live/
                    dead staining of F. nucleatum, (j) quantitative analysis of bacteria viability (%).

                                 Development of anti-inflammatory nanoclusters and nanogels

               The common symptoms at the joints such as pain, stiffness
               and  inflammation  generally  refer  to  different  types  of
               arthritis.  The  two  most  common  types  of  arthritis  are
               osteoarthritis  (OA)  and  rheumatoid  arthritis  (RA).  OA  is
               the result of degeneration of joint cartilage, while RA is
               a disease in which the immune system attacks the joints,
               and results in inflammation (Scheme 2). Both diseases are
               now a global concern as they are associated with multiple
               poor outcomes including  higher  medical costs. In India,
               almost 15% of people are affected by arthritis, which is
               higher than many well-known diseases such as diabetes,
               AIDS and cancer. It has been projected that by 2025, India
               is expected to be at top rank in chronic diseases, unless we   Scheme: Schematic of (a) healthy joint, joint with (b) OA
               find a solution.                                                     and (c) RA.
               To address these challenges, we are trying to bring back
               the earlier used gold therapy in the form of renal clearable
               gold nanoclusters (Au NCs). We are particularly developing
               high-quality AuNCs functionalized with a thiol ligand for
               controlling the inflammation triggered by RA and OA.
               So  far,  we  have  developed  a  unique  Au  NCs  (Figure  3),
               which shows high biocompatibility, and anti-inflammatory
               properties both as individual entities as well as composites
               (Figure 4). We plan to incorporate them in nanogel and
               use them further for the treatment of arthritis.





                                                                 Figure:  Pro-inflammatory (A) TNF-α, (B) IL-6, (C) IL-1β, (D)
                                                                 IP-10,  (E)  IL-12p40  (F)  IL-23,  and  anti-inflammatory  (G)
                                                                 IL-10, (H) IL-1RA and (I) arginase cytokines expression of
                                                                 macrophages treated by zeolite (Z), zeolite-amine (ZA) and
                                                                 Au NCs decorated zeolite-amine (ZANC).




               Figure:  TEM image of the glutathione protected Au NCs.
          54                                                                         ANNUAL REPORT 2021-22
   51   52   53   54   55   56   57   58   59   60   61